A Tale of Two Markets for AIDS Vaccine (Developed vs. Developing World)

Lecture Description

The major market for the AIDS vaccine is in the developing world, says Francis, but there is significant demand in the United States with 40,000 new cases a year.  There are a lot of unknowns in the business climate in the United States affecting the profitability of a vaccine.  It is difficult to encourage investment when a blockbuster drugs would have a much higher rate of return, he adds.

Course Index

1. Don Francis's Mission - Kids and Kids' Health
2. Vaccines Have a Social Problem!
3. A Tale of Two Markets for AIDS Vaccine (Developed vs. Developing World)
4. The Vaxgen Story
5. Bush and 9/11 Put AIDS on the Back Burner - And a New Social Venture is Born
6. Intellectual Property Issues Between Vaxgen and the New Social Venture
7. Non-profit vs. Free Market: The Gates Foundation Changes the Game
8. Is HIV Vaccine Possible?
9. Career Advice: Follow Your Passion and Come to the Bay Area!
10. Alliances and Collaboration